As usual, Teva Pharmaceutical Industries has big plans. It has stated that it wants to reach $31 billion in revenues by 2015. To do that, the Israeli drugmaker plans to grow not only in the generics sector--where it's already the biggest in the world--but in branded drugs. And it expects $2.4 billion of the new revenue to come from respiratory meds.
Read more on Teva's plans here (link no longer available)